Sulfonylurea Glimepiride: A Proven Cost Effective, Safe and Reliable War Horse in Combating Hyperglycemia in Type 2 Diabetes

ISSN Print: 2160-5831
ISSN Online: 2160-5858
www.scirp.net/journal/jdm
E-mail: [email protected]

Citations

"Sulfonylurea Glimepiride: A Proven Cost Effective, Safe and Reliable War Horse in Combating Hyperglycemia in Type 2 Diabetes"
written by Udaya M. Kabadi,
published by Journal of Diabetes Mellitus, Vol.5 No.4, 2015

has been cited by the following article(s):

[1]	Comparison of sitagliptin, glimepiride, and metformin group with glimepiride and metformin group in treatment of diabetes mellitus type 2 patients
	Journal of Pharmacology and Drag …, 2022

[2]	Liquid‐Assisted Grinding Mechanochemistry in the Synthesis of Pharmaceuticals
	2021

[3]	Protonation and anion-binding properties of aromatic sulfonylurea derivatives
	2021

[4]	Role of Gliclazide in Safely Navigating Type 2 Diabetes Mellitus Patients Towards Euglycemia: Expert opinion from India
	2021

[5]	LEADER TRIAL: IMPROVEMENT IN CARDIOVASCULAR OUTCOMES WITH LIRAGLUTIDE IN TYPE 2 DIABETES MELLITUS; EFFECT OF GLYCEMIC …
	2020

[6]	A possible alternative therapy for type 2 diabetes using Myristica fragrans Houtt in combination with glimepiride: in vivo evaluation and in silico support
	2020

[7]	A facile synthesis of sulfonylureas via water assisted preparation of carbamates
	Organic & Biomolecular Chemistry, 2017

[8]	Comparison of the efficacy and safety of Glimepiride and Glipizide as add-on therapy with metformin in patients of type 2 diabetes mellitus
	2017

[9]	Urinary Metabolomic Profiling in Zucker Diabetic Fatty Rats with Type 2 Diabetes Mellitus Treated with Glimepiride, Metformin, and Their Combination
	Molecules, 2016

[10]	The Current Status of New Antidiabetic Drugs
	Journal of pharmacopuncture, 2016

[1]	Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure British Journal of Clinical Pharmacology, 2025 DOI:10.1002/bcp.70162

[2]	Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India Endocrine and Metabolic Science, 2021 DOI:10.1016/j.endmts.2021.100102

[3]	Liquid‐Assisted Grinding Mechanochemistry in the Synthesis of Pharmaceuticals Advanced Synthesis & Catalysis, 2021 DOI:10.1002/adsc.202001245

[4]	Protonation and anion-binding properties of aromatic sulfonylurea derivatives RSC Advances, 2021 DOI:10.1039/D1RA04738H

[5]	A possible alternative therapy for type 2 diabetes using Myristica fragrans Houtt in combination with glimepiride: in vivo evaluation and in silico support Zeitschrift für Naturforschung C, 2020 DOI:10.1515/znc-2019-0134

[6]	A facile synthesis of sulfonylureas via water assisted preparation of carbamates Org. Biomol. Chem., 2017 DOI:10.1039/C7OB00872D

[7]	Urinary Metabolomic Profiling in Zucker Diabetic Fatty Rats with Type 2 Diabetes Mellitus Treated with Glimepiride, Metformin, and Their Combination Molecules, 2016 DOI:10.3390/molecules21111446

[8]	The Current Status of New Antidiabetic Drugs Journal of Pharmacopuncture, 2016 DOI:10.3831/KPI.2016.19.029